September 28, 2026
A new international trial, coordinated through the UAB Mary Heersink Institute for Global Health and the Center for Research in Women’s Health, will test whether a widely available drug can save the lives of mothers with peripartum cardiomyopathy. The National Heart, Lung, and Blood Institute (NHLBI)Opens an external link., part of the National Institutes of Health (NIH),Opens an external link. has awarded funding over seven years for the GLobal trial Of Bromocriptine for PeriPartum CardioMyopathy (GLOBal PPCM), establishing the largest and most diverse global research network addressing this disease.